#Botox

Last 30 Days 📈 Bullish 📈1

📈 Stocks

AbbVie Q2 Earnings Top Estimates; Botox Demand Revival Lifts Outlook

July 31, 2026 (17 days ago)

AbbVie beat Q2 earnings estimates fueled by Botox demand revival, sending shares higher.

ABBV

🌍 US Read More →

📈 Stocks

July 1, 2026 (47 days ago)

Galderma shares sank after the FDA rejected its Botox rival Relfydess, delaying U.S. market entry and strengthening AbbVie's grip on the aesthetics…

GALD ABBV

🌍 CH Read More →